GlaxoSmithKlineItem # 582311MPN 58160-0849-52

Shingrix Zoster Vaccine Adult 50 mcg 5 mLPFS, 10/BX

In StockPrescription required

This item is prescription-controlled. A valid medical license must be on file for your account before it can be ordered.

SHINGRIX
Zoster Vaccine Recombinant, Adjuvanted

SHINGRIX is a vaccine indicated for prevention of herpes zoster (HZ) (shingles):

in adults aged 50 years and older

in adults aged 18 years and older who are or will be at increased risk of HZ due to immunodeficiency or immunosuppression caused by known disease or therapy

One vial of lyophilized powder and one vial of liquid suspension MUST BE COMBINED BEFORE USE.

For 50 Years of Age and Older and For 18 Years of Age and Older who are Immunocompromised and at Increased Risk of Herpes Zoster.

Contents:

1 Vial containing Lyophilized gE Antigen Component

1 Vial containing Adjuvant Suspension Component

After reconstitution, a single dose of SHINGRIX is 0.5 mL

10 doses per pack

Manufacturer: GlaxoSmithKline
Sold By: Pack of 10

How effective is Shingrix compared to other shingles vaccines currently available?

Shingrix is designed to be a highly effective vaccine for the prevention of herpes zoster (shingles), particularly in older adults and immunocompromised individuals, though specific comparative effectiveness data against other vaccines is not provided in the available documentation [Manufacturer Info].

What should a healthcare professional know about the administration process of this vaccine?

Healthcare professionals should be aware that Shingrix requires reconstitution of a lyophilized powder with a liquid adjuvant suspension before administration, and each reconstituted dose is 0.5 mL [Manufacturer Info].

Are there any specific storage conditions required for the Shingrix vaccine vials?

While specific storage conditions for Shingrix are not detailed in the provided information, vaccines of this type are generally stored refrigerated between 2°C and 8°C [Industry Standards].

For an immunocompromised patient, how soon after receiving Shingrix can they expect protection against shingles?

Immunocompromised patients may expect to begin developing protection against shingles within weeks after vaccination with Shingrix, but individual response rates can vary based on the severity of immunosuppression [Manufacturer Info].

What are the most common side effects one might experience after receiving a dose of Shingrix?

Common side effects of Shingrix may include local reactions like pain and swelling at the injection site, as well as systemic symptoms such as muscle pain, fatigue, and headache [Manufacturer Info].

Shingrix Zoster Vaccine Adult 50 mcg 5 mLPFS, 10/BX

Shingrix Zoster Vaccine Adult 50 mcg 5 mLPFS, 10/BX

Shingrix Zoster Vaccine Adult 50 mcg 5 mLPFS, 10/BX

Frequently bought together

Engerix Hepatitis B Vaccine Adult 20 mcg/mL 1 mL SDV, 10/Pk

Engerix-B Hepatitis B Vaccine Adult 20 mcg/mL 1 mL PFS, 10/Pk

Shingrix Zoster Vaccine Adult 50 mcg 5 mLPFS, 10/BX

Frequently bought together

Engerix Hepatitis B Vaccine Adult 20 mcg/mL 1 mL SDV, 10/Pk

Engerix-B Hepatitis B Vaccine Adult 20 mcg/mL 1 mL PFS, 10/Pk

Frequently bought together

Engerix Hepatitis B Vaccine Adult 20 mcg/mL 1 mL SDV, 10/Pk

Engerix-B Hepatitis B Vaccine Adult 20 mcg/mL 1 mL PFS, 10/Pk

Frequently bought together

Engerix Hepatitis B Vaccine Adult 20 mcg/mL 1 mL SDV, 10/Pk

Engerix-B Hepatitis B Vaccine Adult 20 mcg/mL 1 mL PFS, 10/Pk